Audit of Indian Clinical trials on COVID-19

Not Applicable

Completed

• Conditions: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

• Registration Number: CTRI/2021/03/031687
• Lead Sponsor: I

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-04-01
• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 1071

Inclusion Criteria

all studies registered under CTRI for COVID-19 infections in the year 2020 and 2021

Exclusion Criteria

Studies not related to COVID-19

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.Total number of trials/studies registered for COVID-19 <br/ ><br>2.Phase, (Phase I–IV) <br/ ><br>3.Nature (interventional or observational) <br/ ><br>4.Source of funding (Pharmaceutical Industry/Government of India/Institute Funded) <br/ ><br>5.Status of DCGI approval <br/ ><br>6.Status of Ethics committee approval <br/ ><br>7.National/International <br/ ><br>8.Health type <br/ ><br>9.Severity of the condition <br/ ><br>10.Randomization type <br/ ><br>11.Blinding <br/ ><br>12.Primary and secondary end points <br/ ><br>13.Sample size <br/ ><br>14.Duration <br/ ><br>Timepoint: At the end of the study

Secondary Outcome Measures

Name	Time	Method
Total number of trials/studies registered for COVID-19 <br/ ><br>2.Phase, (Phase I–IV) <br/ ><br>3.Nature (interventional or observational) <br/ ><br>4.Source of funding (Pharmaceutical Industry/Government of India/Institute Funded) <br/ ><br>5.Status of DCGI approval <br/ ><br>6.Status of Ethics committee approval <br/ ><br>7.National/International <br/ ><br>8.Health type <br/ ><br>9.Severity of the condition <br/ ><br>10.Randomization type <br/ ><br>11.Blinding <br/ ><br>12.Primary and secondary end points <br/ ><br>13.Sample size <br/ ><br>14.Duration <br/ ><br>Timepoint: At the end of the study